Literature DB >> 8875408

Improved centric phase encoding orders for three-dimensional magnetization-prepared MR angiography.

A H Wilman1, S J Riederer.   

Abstract

New centric phase encoding orders are introduced for transient state three-dimensional MR imaging. Unlike previous centric orders, these variants are not fixed with respect to differences in the relative y and z fields of view, but are tailored to account for the, differential degrees of gradient dephasing in the Ky and Kz phase encoding directions and thus maintain the highest weighting for the most central k-space values. The new centric orders are compared with previous methods in both simulation and experimental magnetization-prepared MR angiography of the carotid and renal arteries. In comparison with other tested centric orders, the new methods provided better retention of true vessel shape caused by isotropic blurring across the phase encoding plane. In addition, the new methods provided increased contrast, with the degree of improvement over previous methods depending on vessel orientation, size, and degree of inflow.

Mesh:

Year:  1996        PMID: 8875408     DOI: 10.1002/mrm.1910360309

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  15 in total

1.  3D contrast-enhanced MR angiography using fluoroscopic triggering and an elliptical centric view order.

Authors:  S J Riederer; S B Fain; D G Kruger; R F Busse
Journal:  Int J Card Imaging       Date:  1999-04

2.  Real-time imaging and triggering of 3D contrast-enhanced MR angiograms using MR fluoroscopy.

Authors:  S J Riederer; S B Fain; D G Kruger; R F Busse
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

3.  Improved venous suppression and spatial resolution with SENSE in elliptical centric 3D contrast-enhanced MR angiography.

Authors:  Houchun H Hu; Ananth J Madhuranthakam; David G Kruger; John Huston; Stephen J Riederer
Journal:  Magn Reson Med       Date:  2004-10       Impact factor: 4.668

4.  Combination of 2D sensitivity encoding and 2D partial fourier techniques for improved acceleration in 3D contrast-enhanced MR angiography.

Authors:  Houchun H Hu; Ananth J Madhuranthakam; David G Kruger; James F Glockner; Stephen J Riederer
Journal:  Magn Reson Med       Date:  2006-01       Impact factor: 4.668

5.  In vivo T(1rho) mapping in cartilage using 3D magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots (3D MAPSS).

Authors:  Xiaojuan Li; Eric T Han; Reed F Busse; Sharmila Majumdar
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

6.  3D magnetization-prepared imaging using a stack-of-rings trajectory.

Authors:  Holden H Wu; Dwight G Nishimura
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

7.  Three-dimensional fluid-suppressed T2-prep flow-independent peripheral angiography using balanced SSFP.

Authors:  Neal K Bangerter; Tolga Cukur; Brian A Hargreaves; Bob S Hu; Jean H Brittain; Danny Park; Garry E Gold; Dwight G Nishimura
Journal:  Magn Reson Imaging       Date:  2011-06-25       Impact factor: 2.546

8.  Contrast-enhanced MR angiography of the abdomen with highly accelerated acquisition techniques.

Authors:  Petrice M Mostardi; James F Glockner; Phillip M Young; Stephen J Riederer
Journal:  Radiology       Date:  2011-09-07       Impact factor: 11.105

Review 9.  High temporal and spatial resolution 3D time-resolved contrast-enhanced magnetic resonance angiography of the hands and feet.

Authors:  Clifton R Haider; Stephen J Riederer; Eric A Borisch; James F Glockner; Roger C Grimm; Thomas C Hulshizer; Thanila A Macedo; Petrice M Mostardi; Phillip J Rossman; Terri J Vrtiska; Phillip M Young
Journal:  J Magn Reson Imaging       Date:  2011-07       Impact factor: 4.813

10.  Three-dimensional magnetization-prepared imaging using a concentric cylinders trajectory.

Authors:  Kie Tae Kwon; Holden H Wu; Taehoon Shin; Tolga Cukur; Michael Lustig; Dwight G Nishimura
Journal:  Magn Reson Med       Date:  2013-07-01       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.